David A Shore

Title: David A Shore: Innovator in Influenza Research

Introduction

David A Shore is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of influenza research, holding a total of 2 patents. His work focuses on developing innovative solutions for the detection and treatment of influenza infections.

Latest Patents

David A Shore's latest patents include the development of potent anti-influenza A neuraminidase subtype N1 antibodies. These isolated monoclonal antibodies and antigen binding fragments specifically bind to the neuraminidase (NA) of an N1 subtype influenza virus. They can be utilized for the detection of the N1 subtype influenza virus and for determining the immunogenicity of vaccines. Additionally, these antibodies and fragments can be employed in the treatment of subjects to prevent or ameliorate influenza infections. Another significant patent involves novel influenza antigens and immunogenic or vaccine compositions, along with methods for producing these antigens and compositions.

Career Highlights

Throughout his career, David A Shore has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and GlaxoSmithKline Biologicals SA. His experience in these institutions has allowed him to contribute to groundbreaking research in the field of virology.

Collaborations

David has collaborated with notable colleagues, including Hongquan Wan and James Stevens. Their combined expertise has further advanced the research and development of effective influenza treatments.

Conclusion

David A Shore's innovative work in influenza research has led to significant advancements in the detection and treatment of influenza infections. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.